4,6-Dibromo-2-fluoro-3-methoxybenzaldehyde, 98%, 500mg

2-Chloro-5h,6h,7h,8h-pyrido[3,4-d]pyrimidin-8-one, 98%, 100mg

2-(4-Fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid, 95.0%, 5g

(S)-2-Methyl-pyrrolidine hydrochloride, 95.0%, 25g

tert-Butyl 4-phenylpiperidine-1-carboxylate, 95.0%, 1g

3-BROMO-6-METHOXYPYRAZOLO[1,5-A]PYRIMIDINE, 95.0%, 250mg

4-Bromo-2,5-difluoro-N,N-dimethylbenzamide, 97%, 1g

2-(4-(2-Fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol, 98%, 10mg

5-Hydroxypyrazine-2-carboxylic acid, 97.0%, 500g

3-Methylpyrrolidine-3-carboxylic acid hydrochloride, 97%, 100mg

2-Amino-5-methylthiazole, 98.0%, 25g

5H-Pyrrolo[2,3-b]pyrazine-7-carboxylic acid, 95.0%, 1g

Malonic acid, min. 99%, for synthesis, 100 g, glass packaging